|
|
Volumn 347, Issue 12, 2002, Pages 947-948
|
|
Diabetic nephropathy [3] (multiple letters)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
CREATININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IRBESARTAN;
LOSARTAN;
POTASSIUM;
ANGIOTENSIN II;
ANGIOTENSIN RECEPTOR;
ANTIHYPERTENSIVE AGENT;
CREATINE;
CONTRAST MEDIUM;
NONSTEROID ANTIINFLAMMATORY AGENT;
ANTIHYPERTENSIVE THERAPY;
CLINICAL TRIAL;
CREATININE BLOOD LEVEL;
DIABETIC NEPHROPATHY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG RESPONSE;
FOLLOW UP;
GLOMERULUS FILTRATION RATE;
HUMAN;
HYPERKALEMIA;
KIDNEY FAILURE;
LETTER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
TREATMENT INDICATION;
BLOOD;
DRUG ANTAGONISM;
HYPERTENSION;
NOTE;
DRUG CONTRAINDICATION;
ANGIOTENSIN II;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CREATINE;
DIABETES MELLITUS, TYPE 2;
DIABETIC NEPHROPATHIES;
HUMANS;
HYPERTENSION;
RECEPTORS, ANGIOTENSIN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CONTRAST MEDIA;
|
|
EID: 0037136572
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200209193471218 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
